ES410825A1 - Quinoline derivatives - Google Patents

Quinoline derivatives

Info

Publication number
ES410825A1
ES410825A1 ES410825A ES410825A ES410825A1 ES 410825 A1 ES410825 A1 ES 410825A1 ES 410825 A ES410825 A ES 410825A ES 410825 A ES410825 A ES 410825A ES 410825 A1 ES410825 A1 ES 410825A1
Authority
ES
Spain
Prior art keywords
quinoline derivatives
quinoline
medicines
inclusion
translation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES410825A
Other languages
Spanish (es)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Synthelabo SA
Original Assignee
Synthelabo SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synthelabo SA filed Critical Synthelabo SA
Publication of ES410825A1 publication Critical patent/ES410825A1/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/088—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38—Nitrogen atoms
    • C07D215/42—Nitrogen atoms attached in position 4
    • C07D215/44—Nitrogen atoms attached in position 4 with aryl radicals attached to said nitrogen atoms

Abstract

Procedure for preparing new derivatives of quinoline, its pharmaceutically acceptable organic and mineral acid addition salts, useful for inclusion in medicines as active ingredients. (Machine-translation by Google Translate, not legally binding)
ES410825A 1972-01-21 1973-01-20 Quinoline derivatives Expired ES410825A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7202035A FR2168227B1 (en) 1972-01-21 1972-01-21

Publications (1)

Publication Number Publication Date
ES410825A1 true ES410825A1 (en) 1975-12-16

Family

ID=9092249

Family Applications (1)

Application Number Title Priority Date Filing Date
ES410825A Expired ES410825A1 (en) 1972-01-21 1973-01-20 Quinoline derivatives

Country Status (5)

Country Link
JP (1) JPS5026548B2 (en)
BE (1) BE794226A (en)
ES (1) ES410825A1 (en)
FR (1) FR2168227B1 (en)
GB (1) GB1390867A (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2280634A2 (en) * 1974-07-31 1976-02-27 Synthelabo 4-Phenyl-piperazino-alkyl anthranilate deriv prepn. - from 2-nitro-benzoic acid via acid halide or salts, condensation with phenyl-piperazino-alkyl radical and reduction
JPS54128241U (en) * 1978-02-28 1979-09-06
JPS6011483A (en) * 1983-06-29 1985-01-21 Taiho Yakuhin Kogyo Kk Piperazine compound
US7105682B2 (en) 2001-01-12 2006-09-12 Amgen Inc. Substituted amine derivatives and methods of use
US6995162B2 (en) 2001-01-12 2006-02-07 Amgen Inc. Substituted alkylamine derivatives and methods of use
US6878714B2 (en) 2001-01-12 2005-04-12 Amgen Inc. Substituted alkylamine derivatives and methods of use
US7102009B2 (en) 2001-01-12 2006-09-05 Amgen Inc. Substituted amine derivatives and methods of use
US20030134836A1 (en) 2001-01-12 2003-07-17 Amgen Inc. Substituted arylamine derivatives and methods of use
US6864255B2 (en) 2001-04-11 2005-03-08 Amgen Inc. Substituted triazinyl amide derivatives and methods of use
US7307088B2 (en) 2002-07-09 2007-12-11 Amgen Inc. Substituted anthranilic amide derivatives and methods of use
US8247556B2 (en) 2005-10-21 2012-08-21 Amgen Inc. Method for preparing 6-substituted-7-aza-indoles

Also Published As

Publication number Publication date
GB1390867A (en) 1975-04-16
JPS4880574A (en) 1973-10-29
DE2302708B2 (en) 1977-03-17
FR2168227B1 (en) 1975-03-14
BE794226A (en) 1973-07-18
JPS5026548B2 (en) 1975-09-01
FR2168227A1 (en) 1973-08-31
DE2302708A1 (en) 1974-05-16

Similar Documents

Publication Publication Date Title
NO140589C (en) ANALOGICAL PROCEDURE FOR PREPARING NEW THERAPEUTICALLY ACTIVE 3,4-DIHYDROCARBOSTYRIL DERIVATIVES
NO142400C (en) ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE NEW BENZIMIDAZOLINON DERIVATIVES
ES410825A1 (en) Quinoline derivatives
SE381047B (en) PROCEDURE FOR PREPARATION OF 3-SUBSTITUTED 1,2-BENSISOXAZOLE DERIVATIVES
ES369624A1 (en) Alkanolamine derivatives
ES425514A1 (en) Coumarin derivatives for the treatment of allergies
HU175933B (en) Process for producing 4-hydroxy-3,5-dialkyl-phenyl-propionic acid derivatives and pharmaceutical compositions containing ttem as active agents
ES329052A1 (en) Method of production of pharmaceutical preparations. (Machine-translation by Google Translate, not legally binding)
ES451880A1 (en) Toothpaste compostion
ES454085A1 (en) Procedure for the preparation of N- (r-tetrahydrofurfuril) -noroximorphone and N- (s-tetrahydrofurfuril) -noroximorphone new. (Machine-translation by Google Translate, not legally binding)
FI49504C (en) Process for the preparation of pharmacologically active benzocycloheptaquinoline derivatives.
ES419913A1 (en) Antiinflammatory compositions
ES469749A1 (en) Nitroimidazole composition
ZA739650B (en) New derivatives of prestanoic acid, process for preparing them and pharmaceutical compositions
ES377723A1 (en) Improvements in pharmaceutical compositions
ES420149A1 (en) Derivatives of n-acetylthiazolidine-4-carboxylic acid
GB1394397A (en) Chlorphenesin derivatives and method of making same
IL42309A0 (en) New heterocyclic derivatives,preparation process and pharmaceutical compositions
ES415452A1 (en) Procedure for the preparation of N-ethyl-2-pirrolylllymehyl-2-metoxy-5-etisulfonyl-benzamide. (Machine-translation by Google Translate, not legally binding)
ES370500A1 (en) Procedure for the preparation of the hydracide. (Machine-translation by Google Translate, not legally binding)
GB1070310A (en) 4-aminoquinoline derivatives
ES375563A1 (en) Pharmaceutical compositions
RO68719A2 (en) PROCEDURE FOR PREPARATION OF DERIVATIVES OF 6-AMINOPENICYLIC ACID
ES427954A1 (en) Preparation of n * n*n** tricyclohexylln * n*n**trimethyll triamidephosphate
ES428270A1 (en) Procedure for preparing the sec. Butil-2-methyl-1 nitro-5 imidazol. (Machine-translation by Google Translate, not legally binding)